Home › Trial NCT06078306
CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).
- Trial IDNCT06078306
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorThe First Affiliated Hospital of Soochow University
- Enrollment20
- Start date2024-04-20
- ConditionsB Acute Lymphoblastic Leukemia · Ph-Negative ALL · High Risk Acute Lymphoblastic Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.